Rankings
▼
Calendar
VCEL Q4 2023 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$65M
+23.3% YoY
Gross Profit
$49M
74.6% margin
Operating Income
$13M
19.6% margin
Net Income
$13M
20.0% margin
EPS (Diluted)
$0.26
QoQ Revenue Growth
+42.6%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$2M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$354M
Total Liabilities
$128M
Stockholders' Equity
$226M
Cash & Equivalents
$69M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65M
$53M
+23.3%
Gross Profit
$49M
$38M
+26.8%
Operating Income
$13M
$6M
+109.2%
Net Income
$13M
$6M
+119.4%
Revenue Segments
MACI Implants And Kits
$94M
100%
← FY 2023
All Quarters
Q1 2024 →